The Latest Breaking News from FDA

The CDC and FDA, when confronted with scarce vaccine supply, refuse to learn from their COVID-19 mistakes.

The administration declares monkeypox a public health emergency and says it will make it easier to get vaccines to patients.

Plus: Schools surveilling students online, Tim Wu leaving the White House, and more...

Here's a roundup of top developments in the biotech space over the last 24 hours:

The cigarette is the only legal consumer product that – when used as intended – causes the premature death of half of long-term users.

Alternate monkeypox treatment caught in regulatory delays

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Here's a roundup of top developments in the biotech space over the last 24 hours:

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

The stock market has witnessed a rough ride amid macroeconomic headwinds this year. Despite the GDP decline for two consecutive quarters, economists believe the economy is far from recession. Here are five fundamentally solid value stocks AstroNova (ALOT), Bristol-Myers Squibb (BMY), Bluegreen Vacations (BVH), GSK (GSK), and Honda Motor (HMC),…